Publication | Closed Access

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA

VaccinationDeleted Lpxl2Vaccine DevelopmentPathogenesisImmunologyPhase 1MicrobiologyInfection ControlStable ExpressionVaccine DesignMedicineVaccine ResearchClinical Microbiology